Art

J-GLOBAL ID：201902263435638454   Reference number：19A0607691

心血管疾患の残余リスクとEPA製剤の有用性

Author (2)： WATANABE TETSU (山形大 医 内科学第一) ,  WATANABE MASAFUMI (山形大 医 内科学第一)
Material： 循環器内科  (Cardioangiology)
Volume： 85  Issue： 3  Page： 434-439  Publication year： Mar. 28, 2019 
JST Material Number： Y0038A  ISSN： 1884-2909  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *cardiovascular event ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0607691&from=J-GLOBAL&jstjournalNo=Y0038A") }}

JST classification (2)： Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M) ,  Treatment for metabolic diseases,nutritional diseases.  (GD05030F)

Substance index (1)： Eicosapentaenoic Acid

Reference (22)：

• Baigent C, Blackwell L, Emberson J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol : a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010 ; 376: 1670.
• Cannon CP, Blazing MA, Giugliano RP, et al. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med 2015 ; 372 : 2387.
• Sabatine MS, Giugliano RP, Keech AC, et al. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. N Engl J Med 2017 ; 376 : 1713.
• Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med 2017 ; 377 : 1119.
• Miyagawa N, Miura K, Okuda N, et al. Long-chain n-3 polyunsaturated fatty acids intake and cardiovascular disease mortality risk in Japanese : a 24-year follow-up of NIPPON DATA80. Atherosclerosis 2014 ; 232 : 384.

Terms in the title (5)： 心血管疾患 ,  リスク ,  EPA ,  製剤 ,  有用性